
Genetically Modified T Cells Might Help Fight HIV
Preliminary work in monkeys suggests stem cells can be engineered to help combat the virus
Preliminary work in monkeys suggests stem cells can be engineered to help combat the virus
The Boston University offering teaches students crucial coping skills
The historic treatment’s costs could top $1 million
The three-year-old policy had “paused” 21 publicly-funded projects
It hasn’t been compared with traditional drugs or therapy
Scientists hope to test experimental therapies on these “micro-brains”
A gold standard trial found the approach does not help patients
The reason for the sudden surge remains a mystery
Some Republicans argue industry players can use their experience to pursue reforms
Spokesperson cites president’s foreign travel as reason; one winner says he’s “relieved”
Wartime clinicians have taught us a lot about fighting infection
“Micro quasi-brains” could aid disease research, but trigger ethical concerns
Antibodies from a first bout can raise the risk of more severe disease if the virus is contracted later
The NASA-funded work compares MRIs before and after trips
Operations after noon have fewer bad outcomes
The move makes it easier for treatment to be prescribed remotely, but does not allocate more money for the crisis
A company called Kick wants to market to the masses a heart medication that would be used for reversing stage fright. Some medical professionals are getting agitated
The pricey therapy is designed for adults with advanced lymphoma
Researchers hope blood and brain scans may detect new clues
The goal is to build a DIY movement to undercut high drug prices
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account